Research ExplorerPublicationsHalf-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodi...

Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees

Standard

Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees. / Herzberg, Jonas; Vollmer, Tanja; Fischer, Bastian; Becher, Heiko; Becker, Ann-Kristin; Sahly, Hany; Honarpisheh, Human; Guraya, Salman Yousuf; Strate, Tim; Knabbe, Cornelius.

In: INT J ENV RES PUB HE, Vol. 18, No. 20, 10972, 19.10.2021.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Herzberg, J, Vollmer, T, Fischer, B, Becher, H, Becker, A-K, Sahly, H, Honarpisheh, H, Guraya, SY, Strate, T & Knabbe, C 2021, 'Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees', INT J ENV RES PUB HE, vol. 18, no. 20, 10972. https://doi.org/10.3390/ijerph182010972

APA

Herzberg, J., Vollmer, T., Fischer, B., Becher, H., Becker, A-K., Sahly, H., Honarpisheh, H., Guraya, S. Y., Strate, T., & Knabbe, C. (2021). Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees. INT J ENV RES PUB HE, 18(20), [10972]. https://doi.org/10.3390/ijerph182010972

Vancouver

Herzberg J, Vollmer T, Fischer B, Becher H, Becker A-K, Sahly H et al. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees. INT J ENV RES PUB HE. 2021 Oct 19;18(20). 10972. https://doi.org/10.3390/ijerph182010972

Bibtex

@article{d48bb05cbb5f42aeb4bc3995c7079a77,
title = "Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees",
abstract = "COVID-19, which is caused by SARS-CoV-2, is an occupational health risk, especially for healthcare employees due to their higher exposure and consequently higher risk of symptomatic and asymptomatic infections. This study was designed to determine the longitudinal seroprevalence of specific immunoglobulin-G (IgG) antibodies in employees in a hospital setting. All employees in a secondary care hospital, including healthcare and non-healthcare workers, were invited to participate in this single-center study. After an initial screening, a 6-month follow-up was carried out, which included serological examination for SARS-CoV-2 IgG antibodies and a questionnaire for self-reported symptoms, self-perception, and thoughts about local and national hygiene and pandemic plans. The seroprevalence of SARS-CoV-2 IgG antibodies was 0.74% among 406 hospital employees (0.75% in healthcare workers, 0.72% in non-healthcare workers), initially recruited in April 2020, in their follow-up blood specimens in October 2020. In this study, 30.54% of the participants reported using the official German coronavirus mobile application and the majority were content with the local and national rules in relation to coronavirus-related restrictions. At the 6-month follow-up, the 0.74% seroprevalence was below the reported seroprevalence of 1.35% in the general German population. The prevalence in healthcare workers in direct patient care compared with that in workers without direct patient contact did not differ significantly. Further follow-up to monitor the seroprevalence in the high-risk healthcare sector during the ongoing global pandemic is essential.",
keywords = "Antibodies, Viral, COVID-19, Health Personnel, Hospitals, Humans, Personnel, Hospital, SARS-CoV-2, Seroepidemiologic Studies",
author = "Jonas Herzberg and Tanja Vollmer and Bastian Fischer and Heiko Becher and Ann-Kristin Becker and Hany Sahly and Human Honarpisheh and Guraya, {Salman Yousuf} and Tim Strate and Cornelius Knabbe",
year = "2021",
month = oct,
day = "19",
doi = "10.3390/ijerph182010972",
language = "English",
volume = "18",
journal = "INT J ENV RES PUB HE",
issn = "1660-4601",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "20",

}

RIS

TY - JOUR

T1 - Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees

AU - Herzberg, Jonas

AU - Vollmer, Tanja

AU - Fischer, Bastian

AU - Becher, Heiko

AU - Becker, Ann-Kristin

AU - Sahly, Hany

AU - Honarpisheh, Human

AU - Guraya, Salman Yousuf

AU - Strate, Tim

AU - Knabbe, Cornelius

PY - 2021/10/19

Y1 - 2021/10/19

N2 - COVID-19, which is caused by SARS-CoV-2, is an occupational health risk, especially for healthcare employees due to their higher exposure and consequently higher risk of symptomatic and asymptomatic infections. This study was designed to determine the longitudinal seroprevalence of specific immunoglobulin-G (IgG) antibodies in employees in a hospital setting. All employees in a secondary care hospital, including healthcare and non-healthcare workers, were invited to participate in this single-center study. After an initial screening, a 6-month follow-up was carried out, which included serological examination for SARS-CoV-2 IgG antibodies and a questionnaire for self-reported symptoms, self-perception, and thoughts about local and national hygiene and pandemic plans. The seroprevalence of SARS-CoV-2 IgG antibodies was 0.74% among 406 hospital employees (0.75% in healthcare workers, 0.72% in non-healthcare workers), initially recruited in April 2020, in their follow-up blood specimens in October 2020. In this study, 30.54% of the participants reported using the official German coronavirus mobile application and the majority were content with the local and national rules in relation to coronavirus-related restrictions. At the 6-month follow-up, the 0.74% seroprevalence was below the reported seroprevalence of 1.35% in the general German population. The prevalence in healthcare workers in direct patient care compared with that in workers without direct patient contact did not differ significantly. Further follow-up to monitor the seroprevalence in the high-risk healthcare sector during the ongoing global pandemic is essential.

AB - COVID-19, which is caused by SARS-CoV-2, is an occupational health risk, especially for healthcare employees due to their higher exposure and consequently higher risk of symptomatic and asymptomatic infections. This study was designed to determine the longitudinal seroprevalence of specific immunoglobulin-G (IgG) antibodies in employees in a hospital setting. All employees in a secondary care hospital, including healthcare and non-healthcare workers, were invited to participate in this single-center study. After an initial screening, a 6-month follow-up was carried out, which included serological examination for SARS-CoV-2 IgG antibodies and a questionnaire for self-reported symptoms, self-perception, and thoughts about local and national hygiene and pandemic plans. The seroprevalence of SARS-CoV-2 IgG antibodies was 0.74% among 406 hospital employees (0.75% in healthcare workers, 0.72% in non-healthcare workers), initially recruited in April 2020, in their follow-up blood specimens in October 2020. In this study, 30.54% of the participants reported using the official German coronavirus mobile application and the majority were content with the local and national rules in relation to coronavirus-related restrictions. At the 6-month follow-up, the 0.74% seroprevalence was below the reported seroprevalence of 1.35% in the general German population. The prevalence in healthcare workers in direct patient care compared with that in workers without direct patient contact did not differ significantly. Further follow-up to monitor the seroprevalence in the high-risk healthcare sector during the ongoing global pandemic is essential.

KW - Antibodies, Viral

KW - COVID-19

KW - Health Personnel

KW - Hospitals

KW - Humans

KW - Personnel, Hospital

KW - SARS-CoV-2

KW - Seroepidemiologic Studies

U2 - 10.3390/ijerph182010972

DO - 10.3390/ijerph182010972

M3 - SCORING: Journal article

C2 - 34682719

VL - 18

JO - INT J ENV RES PUB HE

JF - INT J ENV RES PUB HE

SN - 1660-4601

IS - 20

M1 - 10972

ER -